Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study
Cancer · 2025
DOI: 10.1002/cncr.70122 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer, 2025. Verfasst von Anna Sicuranza und 30 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplastic Stem Cells, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bando Salute Regione Toscana, Associazione Italiana per la Ricerca sul Cancro-Investigator grant, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Background
The authors previously demonstrated that in peripheral blood (PB) of chronic myeloid leukemia (CML), patients’ leukemia stem cells (LSCs) CD26+ are detectable by flow cytometry at diagnosis, during tyrosine kinase inhibitor (TKI) therapy, and during treatment‐free remission.
Methods
This study presents results of a prospective multicenter study including 242 newly diagnosed CML patients monitored for PB CD26+ leukemic stem cells (LSCs) quantification from diagnosis up to 24 months of TKI treatment.
Results
The bulk of CD26+ LSCs at diagnosis varied between patients with a median value of 7.14 cells/µL. During TKI treatment, it has been observed their consistent and rapid reduction without statistical differences according to type of first‐line TKI. Instead, a significant correlation between a low amount of CD26+ LSCs at diagnosis and an optimal molecular response at 3, 12, and 24 months was documented ( p = .03, p = .004, and p = .009, respectively). Three tertiles of CD26+ LSCs correlating to molecular response were identified: 19.21 cells/µL. The incidence of patients with optimal response was higher in the first CD26+ LSCs tertile respect to the third one ( p = .027, p = .015, and p = .079, respectively) at all time points (3, 12 and 24 months).
Conclusions
This study demonstrated a correlation between the amount of CD26+ LSCs at diagnosis and the molecular response, suggesting that the number of CD26+ LSCs at diagnosis could represent an additional tool for predicting TKI response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology Unit, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
- Sant'Eugenio Hospital, Tor Vergata University, Rome, Italy.
- Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Hematology-Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
- Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Division of Hematology, Città Della Salute e Della Scienza, Turin, Italy.
ORCID-Profile: Anna Sicuranza, Elisabetta Abruzzese, Daniele Cattaneo, Alessandra Iurlo, Valentina Giai
Förderung
- Bando Salute Regione Toscana
- Associazione Italiana per la Ricerca sul Cancro-Investigator grant
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Sicuranza, A., Pacelli, P., Santoni, A., Abruzzese, E., Cattaneo, D., Iurlo, A., Luciano, L., Galimberti, S., Giai, V., Mulas, O., Caocci, G., Sorà, F., Capodanno, I., Crugnola, M., Gozzini, A., Russo, S., Annunziata, M., Fozza, C., Cartocci, A., …, & Bocchia, M. (2025). Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study. Cancer. https://doi.org/10.1002/cncr.70122
Vancouver
Sicuranza A, Pacelli P, Santoni A, Abruzzese E, Cattaneo D, Iurlo A, et al. Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study. Cancer. 2025. doi:10.1002/cncr.70122
BibTeX
@article{Sicuranza2025,
author = {Sicuranza, Anna and Pacelli, Paola and Santoni, Adele and Abruzzese, Elisabetta and Cattaneo, Daniele and Iurlo, Alessandra and Luciano, Luigiana and Galimberti, Sara and Giai, Valentina and Mulas, Olga and Caocci, Giovanni and Sorà, Federica and Capodanno, Isabella and Crugnola, Monica and Gozzini, Antonella and Russo, Sabina and Annunziata, Mario and Fozza, Claudio and Cartocci, Alessandra and Fredducci, Sara and Pacini, Emanuele and Liberati, Anna Marina and Defina, Marzia and Bestoso, Elena and Marzano, Cristina and Tocci, Dania and Miracapillo, Teresa and Turriziani, Camilla and Peccia, Katia and Raspadori, Donatella and Bocchia, Monica},
title = {Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.70122}
}
EUVIMED